Enhanced Fertility, an AI-powered digital platform that reduces fertility diagnosis time from “three years to under 30 days,” plans further expansion to make reproductive healthcare more accessible as the World Health Organization releases its first-ever global guideline on infertility.
In outlining the global challenge of infertility, WHO notes that one in six people of reproductive age are affected and calls for “safer, fairer, and more affordable” access to care, highlighting the significant distress, stigma, and financial hardship many people face while seeking treatment.
According to the UN health agency, in many countries, tests and treatments are funded largely out-of-pocket, and in some settings a single cycle of in vitro fertilization (IVF) can cost double the average annual household income.
The guideline includes 40 recommendations that address prevention, diagnosis, and treatment of infertility. It also encourages governments to integrate fertility care into national health strategies, services, and financing models.
Dr. Tedros Adhanom Ghebreyesus, the organization’s director general, said infertility remains one of the most overlooked public health challenges and a major equity issue globally.
“Millions face this journey alone – priced out of care, pushed toward cheaper but unproven treatments, or forced to choose between their hopes of having children and their financial security. We encourage more countries to adopt this guideline, giving more people the possibility to access affordable, respectful, and science-based care,” he noted.
Against this backdrop, Enhanced Fertility has been developing what it describes not as another fertility clinic or testing company, but as an “infrastructure layer” for reproductive healthcare – combining remote diagnostics, data, and AI to make diagnosis and personalized treatment more affordable and accessible for patients and clinicians.
How the platform works for clinics
The clinic-facing side of the platform provides a fully digitalized fertility pathway. It supports onboarding patients, requesting tests and assessments, and gathering clinical history. Available tests include blood tests, sperm analysis, serologies, genetic tests, scans, and other diagnostic tools.
Clinicians can access the Enhanced Fertility Report, which visualizes patient results and automates diagnostic classifications. The AI-guided system helps predict outcomes, create personalized treatment plans, and monitor medication adherence.
Enhanced Fertility says its tools automate patient intake, speed up lab orders and diagnosis, and support treatment planning.
According to the company, this reduces administrative workload by 30% and clinical time by 2.5 hours per patient, allowing clinics to increase capacity and revenue without additional staff.
How the platform works for patients
For individuals, Enhanced Fertility offers at-home fertility testing and assessments for both women and men.
Users register online, complete a health questionnaire and receive a discrete test kit. Depending on the test, samples can include blood, urine, or sperm.
After the sample is sent back using the provided packaging, a certified laboratory analyzes it. Patients can access their results within 48 hours of processing and then review them in a consultation with a healthcare professional.
Starter tests check the main hormones responsible for reproduction. Female starter tests include AMH, LH, FSH, Estradiol, Prolactin, and Testosterone. Male starter tests include FSH, LH, Testosterone, DHEA-S, and SHBG.
For those who have been trying to conceive longer or are preparing for fertility treatment, the platform offers a wider set of tests to help them move forward in their care.
These include progesterone testing, PCOS and thyroid panels, sexually transmitted disease screening, pregnancy tests, vitamin D, blood group, karyotype, pelvic, endometrial and breast scans, semen analysis with DNA fragmentation, testicular scans, lipid profiles, liver function tests, and additional options. Personalized testing plans are available upon request.
Patient support and scientific validation
Enhanced Fertility outlines several commitments to patients. These include offering inclusive services for all individuals regardless of gender or sexual orientation, providing only clinically justified testing, and giving users full access to their data, which can be downloaded and shared with clinicians.
The company states that its laboratory partners participate in recognized external quality assessment schemes used by accredited medical laboratories. All kits contain validated components, and laboratory analysis is carried out by certified facilities to ensure reliable results.
2025 milestones
In comments to Portugal Startup News, co-founder and CEO Andreia Trigo outlined the company’s main milestones for 2025, noting that Enhanced Fertility developed and validated EnhancedDx, an AI-driven algorithm that automates fertility-related diagnosis, reimbursement coding, and clinical note generation.
The company also expanded across Europe, launched its testing and software services in the United States, and secured a Texas-based lead investor – Eagle Venture Fund – for its €2 million seed round.
Trigo, a multi-award-winning nurse consultant who was diagnosed with infertility at age 17, describes Enhanced Fertility as her life mission to give meaning to her own diagnosis by helping others build their families.
This mission is further supported by her husband, co-founder, and CTO Frank Khan Sullivan, who says he understands the challenges, stigma, and lack of support many men still face when trying to conceive and oversees the technical strategy to ensure accuracy, speed, and personalization within the platform.
Plans for 2026
Looking ahead, Trigo said the company aims to close its seed round in 2026, strengthen its regulatory pathway and intellectual property portfolio, continue its growth across the EU and expand commercial pilots in the U.S.
She added that Enhanced Fertility’s key differentiators include its ability to cut diagnosis time from three years to under 30 days, its service footprint across the United Kingdom, EU, and U.S., and its focus on safe, validated, and clinically compliant AI.
Enhanced Fertility’s expansion plans align with its long-term goal of helping bring one million babies into the world by making fertility diagnostics and treatment faster, more accessible, and more data-driven.
Featured image: Co-founders of Enhanced Fertility: CEO Andreia Trigo (left) and CTO Frank Khan Sullivan (Photo courtesy of Enhanced Fertility)
Portugal Startup News 